Articles

One potential path for reducing Medicare Advantage (MA) overpayments from favorable selection is reforming the current administered payment approaches linking spending in fee-for-service (FFS) to MA rates.

USC Schaeffer Center senior fellow Genevieve Kanter says the risk to patient privacy posed by AI chatbots presents unique challenges.

For the first time in two decades, an Alzheimer’s drug has received full Food and Drug Administration (FDA) approval. USC Schaeffer Center experts are available to discuss this milestone and the challenges ahead.

Ultimately, health systems facing increased risk of AI chatbot breaches must decide whether to discourage clinicians’ use of this technology or embrace it.

A brief assessment in primary care can help identify patients most at risk

Overpayment to Medicare Advantage plans due to favorable selection, “coding intensity” and rating bonuses could exceed $75B in 2023.

Overpayments to Medicare Advantage plans now exceed 20% annually, underscoring the urgent need for reform.

Researchers found that behavioral interventions aimed at improving performance can be designed to protect clinician job satisfaction and improve quality of care.

Researchers looked at cancer therapy trastuzumab (Herceptin) and found biosimilars bring competition to the market, with prices declining by more than half for some versions.

The IRA will be measured not just by how much it can lower prices, but also by whether it continues to encourage drug makers to invest in new treatments.